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Nasal cytology is an important diagnostic tool in nasal disorders, especially those 
regarding nasal mucosa. This technique allows clinicians to observe the morphology 
and the structure of nasal epithelium cells—such as ciliated, mucous-secreting, 
striated, and basal cells—and to detect the presence of degenerative or phlogistic 
phenomena in the respiratory epithelium. Moreover, it makes it easy to identify 
the presence of inflammatory cells, such as neutrophils, eosinophils, and mast 
cell. Over the past few years, nasal cytology allowed researchers to discover new 
clinical issues that were still unexplored: the nonallergic rhinitis with eosinophils, 
the nonallergic rhinitis with mast cells, the nonallergic rhinitis with neutrophils, 
and the nonallergic rhinitis with eosinophils and mast cells. Nasal cytology is easy 
to perform and barely invasive; therefore, it can easily be repeated. Since it makes 
it possible to evaluate the patient’s response to a therapy, the technique is a very 
useful tool in follow-up checks of nasal disorders. We have reported in the following 
chapter our working experience, and we observed the results of cytological exams 
performed in our Center from 2013 to 2018. We therefore developed an easy and 
intuitive classification of sinonasal chronic inflammatory diseases.
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1. Introduction
The nose is composed of two nasal cavities separated by an osteocartilaginous 
structure called nasal septum. The initial portion is called nasal vestibule, while the 
next part is called nasal cavity. The nasal cavity borders on the nasopharynx, from 
which it is separated by the choanae. In the most cranial portion of the nasal fossa, 
we find the olfactory fissure. This region is responsible for the perception of odorous 
stimuli. The nasal cavities are occupied by osseous structures with mucous lining 
called turbinates. These are divided as follows: the inferior turbinate that through its 
cavernous vascular tissue contributes to humidify and heat the inspired air, the middle 
turbinate that anatomically defines a sort of pre-sinus space, and at last the superior 
turbinate. In some cases we also recognize a fourth turbinate called supreme [1].
We observe four different nasal epithelia. A layered keratinized floor epithelium 
covers the region of the nasal vestibule, and an epithelium called transitional is 
located at the level of the valve. On the other hand, the nasal cavities are covered by a 
mucosa with pseudostratified ciliated epithelium (enriched with olfactory cells at the 
level of the olfactory fissure). The ciliated pseudostratified epithelium is composed 
of four types of cells: ciliated cells, muciparous cells, columnar cells, and basal cells, 
anchored by desmosomes and hemidesmosomes. This epithelium is separated from 
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the underlying tonaca propria by a basal membrane. In the context of the tonaca pro-
pria, we can find three layers. At the beginning, just below the basement membrane, 
we can find the lymphoid layer, which is characterized by the richness of lymphocytes 
(nasal-associated lymphoid tissue (NALT)). Then we have the glandular layer, char-
acterized by glands that have a significant immune function producing secretions rich 
in lysozyme and IgA. Last, we can find the vascular layer, characterized by important 
vascular representation, especially in the mucosa of the inferior turbinate [2].
This brief description of microscopic anatomy of the nasal mucosa allows us to 
highlight the many important physiological functions it performs.
First of all, in the respiratory epithelium, the mucociliary clearing action is 
carried out thanks to the cooperation of ciliated and muciparous cells. This process 
is fundamental in determining the circulation of mucus, and therefore it performs 
a nasal cleaning with immuno-protective tasks [3]. At the level of the superficial 
mucous layer (thanks to the presence of lymphatic tissue) and at the level of the 
intermediate glandular layer (thanks to the secretion of lysozyme and IgA), immu-
nocompetence functions are also performed. At last, the vascular layer, thanks to 
the presence of cavernous tissue, allows to change the physical-chemical character-
istics of the air inhaled before its passage in the middle and lower respiratory tract 
[2]. With the passage of air through the nasal cavities, water vapor is transferred 
through the mucosa of the inferior turbinates with consequent lowering of oxygen 
partial pressures [4]. Furthermore, due to the contact between the mucosal surface 
of the turbinate and the air, the heating of the same is ensured [5].
The pathology of the rhinosinusal district appears to be varied and diversified 
[2], and it is characterized by many different types of clinical entities that some-
times are present individually, sometimes they overlap: this creates, in our opinion, 
classification difficulties. Another critical aspect for clinicians is to understand the 
real extent of rhinosinus disease, that is, if we are dealing with an exclusively nasal 
or sinus involvement or an involvement of both districts.
Our experience has led us to use in diagnosis of a rhinosinusopathy both a cytological 
examination of the nasal mucosa that will allow us to identify the problem and a radio-
logical study (better if using cone beam CT) to define the real extent of the problem.
In this discussion we will explain how to perform a cytological examination and 
how to interpret it, and we will try to define a systematic classification of rhinopa-
thies relying on the analysis of cytological compartments of patients affected by 
rhinopathy from our Center in the last 5 years.
2. Materials and methods
For about 10 years, we have been analyzing cytological samples from the lower 
turbinate mucosa in patients with chronic rhinopathies. This type of evaluation 
allowed us to study the microscopic characteristics of the healthy nasal mucosa 
and to identify the characteristic aspects of the different forms of rhinopathy. 
Performing a cytological examination is simple, rapid, and minimally invasive. It is 
also a cost-effective investigation.
From October 2013 to September 2018, we performed cytological sampling and 
subsequent microscopic analysis on the sample obtained from 300 patients with 
chronic rhinopathy. These patients reported suffering from several months or even 
years of nasal respiratory obstruction, rhinorrhea, in some cases complaining of 
recurrent headache or hyposmia or sneezing and nasal itching.
The cytological examination of each patient was performed according to the 
Italian Academy of Nasal Cytology (AICNA) procedures. We briefly summarized 
the modalities in the following paragraph.
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2.1 How to perform a cytological sampling
2.1.1 Sampling
Through a small spoon called Rhino-Probe®, we collect mucous material joined 
to cells of the nasal mucosa, exerting a slight pressure on the body of the inferior 
turbinate. This technique is called nasal scraping (there are other sampling tech-
niques such as brushing, nasal swab, and the washing that we report but of which 
we have no experience).
2.1.2 Processing
The material taken is distributed on a special slide, while avoiding to touch the 
surface of the slide with your fingers while always using gloves.
2.1.3 Fixation and coloring
We proceed to fix the material taken on the slide, then we apply the May-
Grunwald-Giemsa (MGG) coloration. In our experience, we have been using a fast-
acting MGG staining method (MGG Quick Stain®) for some years now. Cytological 
staining method is very numerous and each of them has its own specificity and 
application. In nasal cytology the most widely used is the MGG method which is 
able to easily differentiate the various cells found in the nasal mucosa.
2.1.4 Assembly of the slide
Through a specific synthetic product (Bio Mount HM®) the cover slip is applied 
above the slide. This way, the sample is ready to be observed.
2.2 Microscopic observation
The analysis of the sample of cytology material mounted on the slide is done 






Initially, a general inspection of the material is carried out with a lower magni-
fication objective (4×/0.10). Once the most significant part of the sample has been 
identified, the evaluation will be carried out with increasingly powerful objectives 
to exploit the maximum possible magnification (100×/1.25) with the help of oil for 
immersion.
In accordance with the guidelines of the Italian Academy of Nasal Cytology 
(AICNA), for each sample taken, we analyze at least 50 fields at maximum magni-
fication (100×/25) by counting the different types of cells found. The observed data 
are then shown in a Table 1.
3. Results
We have collected in Figure 1 the results of the cytological tests performed from 
October 2013 to September 2018 (Figure 1).
Of the 300 patients studied, 154 (equal to 53.66%) were affected by a 
pathology of the nasal mucosa of neutrophilic type that is characterized by the 
presence of more or less numerous neutrophil granulocytes. The majority of 
them, 136 patients (88.31%), had chronic nonpolyposis pathology, while only 18 
(11.69%) of them presented a polyposis pathology (Figure 2). The patients with 
nonpolyposis pathology were subjected to cone beam computed tomography 
(CBCT). Ninety-seven patients (71.32%) showed a pathological thickening of 
the paranasal sinuses mucosa. This situation indicates an involvement of the 
paranasal sinuses by the pathology and suggests a diagnosis of chronic rhinosi-
nusitis (Figure 3).
Thirty-four patients, equal to 11.85% of the total, showed a significant presence 
in the nasal mucosa of eosinophilic granulocytes. Of these, 29.41% of patients (10) 
had polyposis, while 70.59% of patients (24) had nonpolyposis (Figure 4).
Only five patients (1.74% of the total) showed instead a significant presence 
of mast cells in the nasal mucosa, and in no case we observed a form of polyposis. 
Finally, 32.75% of patients (94) had a mixed cell infiltration in the samples of nasal 
mucosa (Figure 1). Of these, 23.40% (22 patients) presented a polyposis pathology 
(Figure 5).
We analyzed the cytotypes of the “mixed cellularity rhinosinusopathy” cat-
egory, distinguishing four subclasses: neutrophil-eosinophil forms (50 patients, 
equal to 53.19%), neutrophil-mast cell forms (8 patients equal to 8.51%), 
Figure 1. 
Type of cells in nasal pathology.
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neutrophil-eosinophil-mastocyte forms (24 patients equal to 25.53%), and eosino-
phil-mast cell forms (12 patients equal to 12.77%) as indicated in Figure 6.
In 33 patients (equal to 11% of the total patients studied), we did not find any 
pathological changes in the nasal mucosa.
Figure 2. 
Neutrophil pathology: presence of polyps.
Figure 3. 
Neutrophil nonpolypoid pathology: mucosal thickening.
Figure 4. 
Eosinophil pathology: presence of polyps.
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The picture that emerged from this evaluation allowed us to distinguish nasal 
pathologies in a practical and clear way on the basis of cytological aspects and 
therefore, in our opinion, to simplify their classification. Furthermore, the cyto-
logical characterization allows us to address the therapy in a very personal way and, 
in addition, to periodically evaluate the results in a more rigorous way.
We therefore distinguished the nasosinusal pathologies in groups based on the 
inflammatory cytotype most significantly represented in the analyzed sample:
• Neutrophilic rhinosinusitis
• Eosinophilic rhinosinusitis
• Mast cell rhinosinusitis
However, in some patients we found that it was not possible to define a 
dominant cytotype as the nasal mucosa was quantitatively similarly affected by 
more than one cell type. In these cases we use the term rhinosinusitis with mixed 
cellularity.
Figure 5. 
Mixed pathology: presence of polyps.
Figure 6. 
Types of cells in mixed rhinosinusitis.
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We then divided the mixed cellular rhinosinusitis into four subclasses:
• Neutrophilic-eosinophilic form
• Neutrophilic-mast cell form
• Neutrophil-eosinophil-mastocitary form
• Eosinophilic-mast cell form
3.1 Neutrophil rhinosinusitis
In our experience, it represents the most frequently encountered pathology. This 
condition is characterized by the more or less significant presence of inflammatory 
cells called neutrophils granulocytes.
The neutrophil granulocyte has a roundish shape and presents a clear (“neutral”) 
cytoplasm with a purplish-red polylobate nucleus after MGG staining. The neutro-
phil granulocytes are distinguished in six different types based on the shape of the 
nucleus [2]. It is possible that the number of lobes is related to the age of the cell. In 
fact, in young granulocytes the nucleus often appears to be reniform, while in the 
older ones, it has different lobes.
The neutrophilic granulocyte plays an important immune function defending us 
from pathogenic microorganisms [6] and other irritating substances toward which 
it has an effective phagocytic activity. Once the phagocytosis process has been 
performed, a “killing” function is performed against pathogens thanks to the intra-
cytoplasmic release of substances with a lithic action including hydrogen peroxide, 
superoxide ion, and some enzymes as elastase, lysozyme, collagenase, phosphatase, 
and lactoferrin.
According to Gelardi et al., the presence of sporadic neutrophils in the nasal 
mucosa would not represent an index of pathology. Instead, we have to make a 
diagnosis in case of high number of neutrophils. With infectious rhinosinusitis, the 
number of neutrophil granulocytes increases significantly. They are called back in 
the nasal mucosa in order to engulf the pathogenic microorganisms and eliminate 
them [7]. We observe in Figure 7 some granulocytes with intracytoplasmic bacteria. 
In this image the moment immediately following the phagocytosis is shown, before 
the lithic enzymes are activated for digestive purposes. In the proposed image, we 
observe a bacterial infectious pathology. Microscopic observation can help us to dif-
ferentiate the various types of germs involved in infection. We can in fact recognize 
the round shape of the bacteria as the Staphylococcus Au, the Streptococcus Pn, and 
the Moraxella C. or the elongated shape of the haemophilus I and the diphtheroids. 
Neutrophilic rhinosinusopathy with an infectious etiology may also present a viral 
or fungal etiology. In the latter case, we will observe the presence of fungal spores 
that present themselves with a particular “bulb” shape.
In infectious neutrophil rhinosinusitis, in addition to the increase in neutrophils 
and the presence of microbial agents (Figure 8), we will also be able to see an 
increase in lymphocytes, macrophages, and plasma cells and an increase in mucipar 
cells associated with decreased ciliated cells.
We found very interesting the observation of bluish areas that we define “infec-
tious spots” [2]. Those represent the expression of bacterial biofilm or an exopoly-
saccharide matrix within which fungal bacteria and spores live. The structure of 




In the forms of viral etiology, we will not be able to find pathogenic microorgan-
isms due to the insufficient magnification power of the optical microscope. However, 
we can observe some indirect signs of ciliated cells strongly suggestive of viral 
infection. In fact, they can present both alterations of the nuclear structure (poly-
nucleation) and of the cytoplasmic component (inclusions and separations). Also 
usually in the viral infection, we observe an important increase of the lymphocytes. 
The finding of neutrophils in the nasal mucosa, however, also occurs in cases of 
noninfectious diseases. In these cases we can observe a variable number of neutrophil 
granulocytes without the cytological aspects described above. In this case, we are 
talking about a form of irritating rhinosinusitis in which often the etiologic agent is 
represented by a substance with an irritating action, which can be exogenous (pow-
ders, environmental pollutants, tobacco smoke, and toxic substances present in the 
professional field) or endogenous (gastroesophageal reflux disease) (Figure 9) [8].
In addition to the already described presence of neutrophils we can observe an 
alteration of the normal relationship between ciliate cells and muciparous cells. 
In fact, we often observe a reduction of the former and an increase in the latter. 
In other cases we can observe areas of squamous epithelium. According to some 
authors the severity of these rhinopathies would be associated with the number of 
neutrophils present.
In fact, by releasing their lithic enzymes and their toxic substances, they would cause 
damage to the respiratory mucosa proportional to the quantity of substances released.
Furthermore, in these patients, chronic mucosal damage and consequent altera-
tion of mucociliary clearness would favor greater nasal fragility and a greater risk of 
contracting respiratory infections.
Figure 7. 
Phagocytosis (neutrophil granulocyte with intracytoplasmic bacteria).
Figure 8. 
Infectious neutrophil rhinosinusitis.
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3.2 Eosinophilic rhinosinusitis
This condition is represented by the presence in the nasal mucosa of eosinophilic 
granulocytes. The eosinophilic granulocyte belongs, as well as neutrophil, to the 
group of leukocytes and also presents a roundish form, although of slightly greater 
dimensions. Frequently the nucleus appears bilobed (Figure 10).
The cytoplasm is of variable color from orange to intense pink, very distinctive 
and unmistakable. Inside, small granules are observed that contain substances such 
as the major basic protein (MBP), the eosinophilic cationic protein, and the eosino-
philic peroxidase [9]. These substances have a cytotoxic and antibacterial function. 
In the cytoplasm of eosinophils, we also find enzymes (collagenase, phosphatase, 
and phospholipase) and substances derived from the metabolism of arachidonic 
acid as leukotrienes and prostaglandins (LTC4, PGD2, PGE1). These substances 
play a fundamental role in the mechanisms of inflammation, especially in the 
delayed phase of the allergic reaction (Figure 11).
The LTC4 leukotriene in particular has a bronchoconstriction action as well as 
prostaglandin PGD2, while prostaglandin E1 has a vasodilatory action. Other sub-




Eosinophilous (frequently the nucleus appears bilobed).
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for chemotactic and amplification of the inflammatory processes. We recall 
among these IL2, which performs chemotactic action toward mast cells, IL3 with 
chemotactic action toward eosinophils, and IL5 with chemotactic action toward 
neutrophils [10].
Frequently we have found eosinophilic rhinosinusitis. Of 34 patients with this 
type of pathology, 38.24% (or 13 patients) had allergic rhinitis, the remainder suf-
fered from other forms of rhinitis.
We have found in the 32.35% of subjects (11 patients) a vasomotoria rhinitis and 
in the 29.41% (10 patients) a nasal polyposis.
Eosinophilic rhinosinusitis has very specific clinical features. Affected patients 
complain of a very troublesome symptomatology, often characterized by sneezing 
and rhinorrhea, nasal itching, and nasal congestion. Symptoms can be triggered 
suddenly by the contact of the nasal mucosa with a known allergen, but also by the 
occurrence of some particular stimuli (such as sudden changes in temperature or 
humidity, contact with intense perfumes, tobacco smoke).
Patients with eosinophilic rhinosinusitis are often affected by other eosinophilic 
phenotype disorders such as bronchial asthma. For a long time, we have known 
that the course of the nasal pathology has a singular influence on the prognosis of 
the associated bronchial pathology. For this reason, a correct treatment and a good 
control of the nasal pathology are to be considered necessary.
We know that some granular components of eosinophils, such as major basic 
protein (MBP), have the ability to attack the desmosomal junctions by weakening 
the barrier action of the respiratory mucosa and exposing it to the action harmful 
to infectious chemical or physical agents [11]. Therefore patients suffering from 
eosinophilic rhinosinusitis not only suffer from symptoms that we could define 
direct and that are related to the action of components such as prostaglandins and 
leukotrienes but also indirect symptoms (purulent rhinorrhea, headache, pharyn-
godynia, cough, recurrent fever, episodes of dyspnea) derived from the overlap of 
other diseases favored by the weakening of the mucosal barrier and by the inef-
ficiency of mucociliary clearance.
3.3 Mast cell rhinosinusitis
This condition is characterized by the presence of mast cells in the nasal mucosa. 
The mast cell is presented to the observation with a variable optical microscope: 
it can be vaguely roundish or lozenge shaped. It is characterized by a marked 
basophilia and has a coarsely oval nucleus generally covered by numerous granules 
(Figure 12). They are generally larger in size than eosinophilic granules.
Figure 11. 
Eosinophil rhinosinusitis (we observed an important degranulation reaction).
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The surface of mast cells is characterized by the presence of IgE receptors. When 
they bind to these receptors, the mast cell releases by exocytosis its granules with 
the substances contained therein including histamine, a preformed substance with 
multiple actions [12].
In fact, it acts on the vascular receptors favoring vasodilation and edema of the 
surrounding tissues. It also acts on the nasal glands, feeding the rhinorrhea, and 
stimulates the nerve endings favoring itching and sneezing. The mast cell through 
its granules also eliminates some preformed chemotactic factors such as IL4, IL5, 
and IL13. Arachidonic acid is also synthesized by newly formed metabolites such as 
PGD2 and LTC4, whose actions on smooth muscles and vessels have already been 
described previously.
The mast cell, once stimulated, determines immediate symptoms. This rapidity 
of action can be observed in the early phase of the allergic reaction [13]. However, 
this cell is able, through the release of chemotactic factors, to influence also late 
phlogistic reactions.
As we can show in Figure 1, mast cells are rarely the only cells involved in the 
pathogenesis of a rhinopathy. In fact, we found only 5 cases of mastocytic rhinosi-
nusitis in 300 patients studied (1.67%). Of these patients two presented an allergic 
disease, while three patients had a nonallergic disease.
On the other hand, cases of mixed cellular pathologies with the presence of mast 
cells are very frequent.
Mast cell rhinosinusitis are characterized by very intense symptoms, characterized 
by marked nasal obstruction, serous rhinorrhoea, nasal pruritus, and sneezing. Also 
in this case as in eosinophilous cellularity diseases, we have reestablished an associa-
tion with other pathologies with a similar phenotype such as bronchial asthma.
3.4 Mixed rhinosinusitis
We found a mixed rhinosinusitis in 94 patients corresponding to 32.75% of 
patients with rhinosinusitis and inflammatory phenotype (Figure 1). As we can see 
from the graph below, mixed rhinosinusitis is characterized by the presence in the 
nasal mucosa of several inflammatory cytotypes (Figures 13 and 14).
In 53.19% of the cases (50 patients), we found a pathology characterized by neu-
trophil and eosinophilic infiltration; in 25.53% of cases (24 patients), a type with 
neutrophilia-eosinophilia-mast cell; in 12.77% of cases (12 patients), eosinophilic 
and mast cell type and in 8; and 51% of the cases (8 patients), we found neutrophils 
and mast cells in the nasal mucosa. In many cases, mixed rhinosinusitis is found in 
Figure 12. 
Mast cell with degranulation.
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allergic patients. We have observed that a low intensity but stable and protracted 
allergenic stimulation, as in the case of allergies to Dermatophagoides, produces at a 
cytological level a framework defined by Gelardi et al. “Minimal persistent inflam-
mation” is characterized by the presence of numerous neutrophil granulocytes and 
a small number of eosinophils or mast cells. Another interesting aspec is the greater 
association of the mixed forms with nasal polyposis compared to the other forms of 
rhinosinusitis as shown in the graph below (Figures 15 and 16).
We have indeed observed that in the category of rhinosinusitis with mixed 
cellularity, 23.40% of patients had developed a nasal polyposis, while in the other 
forms of rhinosinusitis, the percentage of patients who developed a nasal polyposis 
is lower (14.51%). The symptoms of this kind of disease varies according to the 
most characterizing cytotype. In any case we must remember how these forms are 
particularly harmful for the nasal mucosa and for mucociliary function, as they, 
according to our clinical experience, contribute in favoring an increased risk of 
respiratory inflammation in those affected.
Figure 13. 
Mixed rhinosinusitis with neutrophil (N), mast cell (M), and lymphocyte (L).
Figure 14. 
Mixed rhinosinusitis with neutrophil (N) and eosinophil (E).
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4. Discussion
Our experience has allowed us to consider the nasal cytological examination as 
indispensable diagnostic tools for a better understanding of chronic inflammatory 
diseases of the rhinosinusal district.
Thanks to the information provided by the cytological examination, we can 
define the etiopathogenetic characteristics of the disease. Obviously the collec-
tion of the anamnesis represents a complementary and indispensable diagnostic 
element.
By carrying out these three diagnostic aspects, we are able to trace the identifica-
tion of the pathology very precisely.
Daily experience has led us to acknowledge the necessity of a simplification 
regarding the classification of rhinosinusal diseases.
Once there was a clear demarcation between pathological processes at nasal 
localization, the rhinitis, from those with sinus localization, the sinusitis.
In agreement with the European guidelines present in the EPOS12 [14], we 
argue that very often the two pathologies are closely related, so that a clear border 
between the two is impossible. We therefore think it is practical as well as appropri-
ate to use in clinical practice a single term that includes the two old forms of nasosi-
nusal pathology. For these reasons, we will talk about chronic rhinosinusitis about 
any chronic inflammatory process that affects the rhinosinusal district.
The teaching of the pulmonologists, as explained in the GINA guidelines, led 
us to consider the nasal pathology narrow related to the bronchial situation. This is 
Figure 15. 
Prevalence of polyposis in mixed rhinosinusitis.
Figure 16. 
Prevalence of polyposis in other types of rhinosinusitis.
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the reason why the phenotypic classification adopted for asthma is, in our opinion, 
extremely suitable also for the rhinosinusal pathology.
We have therefore redesigned the pneumological experience in order to use 
in our daily practice a simple and immediate distinction for the various forms of 




This first distinction in the 2 phenotypic classes arises from the firm belief that 
the clinical characteristics of the sinonasal pathology are closely related to the type 
of cell involved in the inflammatory process.
As shown in Table 1, in the cellular rhinosinusitis group, we contemplate the 
neutrophilic, eosinophilous, mast cell, and mixed cell forms. In the second group, 
(noncellular rhinosinusitis) we contemplate pathologies characterized by a normal 
cytological expression but equally characterized by sinonasal symptoms. Among 
these we include the iatrogenic forms, the hormonal forms, the atrophic forms, the 
mechanical forms (associated with septal dysmorphism), and the decubitus forms 
(characterized by significant nasal respiratory obstruction when the patient lies 
supine). In our case series, the number of patients affected by this type of pathol-
ogy was much lower than patients affected by cellular rhinosinusitis. Precisely the 
individuals affected was 13 (equal to about 4.5%).
Indeed, the number of negative rhinocitograms was superior, almost three times 
as high. However, we have also included in the cellular group patients with negative 
cytological examination; in those cases we knew that the negative result originated 
from temporal circumstances. This applies, for example, to certain diseases with 
seasonal or recurring cellular characterizations. We have therefore attributed to the 
group of eosinophilic rhinosinusitis also those patients with clearly allergic symp-
toms and in which sensitization to seasonal allergens was ascertained despite having 
found in them a normal rhinocytogram. This situation occurs when we performed 
the sampling outside the allergy period.
We are sure of the central role of the cytotype in the sinonasal pathology 
manifestation, and we have also distinguished the mixed rhinosinusitis in four 
subclasses: the neutrophil-eosinophilic cellular form, the neutrophil-mast cell form, 
the neutrophil-eosinophil-mast cell form, and the eosinophilic-mast cell form.
This classification, with the support of an adequate imaging and with a correct 
anamnestic study, allows clinicians to diagnose all types of rhinosinusitis by means 
of an easy and intuitive classification.
The diagnostic classification performed by cytological examination allows a targeted 
therapeutic planning. In fact, the knowledge of the etiopathogenetic and cytological 
principles of a pathology allows a “tailor made” therapeutic planning and also allows to 
achieve a precise monitoring of the pathology. This leads to optimal control of symp-
toms and an inevitable prognostic improvement of chronic inflammatory diseases.
5. Conclusion
The classification of rhinosinusitis is still very complex and diversified today. 
Thanks to the information we can obtain from the nasal cytology and the anam-
nesis, we are able to easily frame the majority of rhinosinus pathologies in order to 
obtain a targeted therapeutic planning and adequate monitoring.
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We have listed the pathologies observed and classified from the cytological point 
of view in 5 years of experience, and we have come to propose a simple and versatile 
classification that takes into account the different clinical and etiopathogenetic 
characteristics of the pathologies observed.
Based on the phenotype, we distinguished cellular rhinosinusitis from noncel-
lular rhinosinusitis. The former are divided into four classes (the neutrophil form, 
the eosinophilic form, the mast cell form, and the mixed form). These types of 
rhinosinusitis are characterized by a specific cytological framework. We then 
grouped rhinosinusitis with a negative rhinocytogram in the noncellular phenotype. 
Among these we remember the iatrogenic forms, the forms on a hormonal base, the 
positional and decubitus, the atrophic, and the mechanical forms.
According to us, the distinction we have proposed is simple and immediate.
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